Leflunomide

Leflunomide

SCHEMBL7650952

C/C(O)=C(\C#N)C(=O)Nc1ccccc1C(F)(F)F.Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHODH

The experimentally established mechanism targets of Leflunomide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH known ✓ Q02127 9/20 0.61
NPC1 O15118 3/20 0.61
RAB9A P51151 3/20 0.61
HTT P42858 2/20 0.61
GMNN O75496 1/20 0.61
LMNA P02545 1/20 0.61
TP53 P04637 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
HTR1A P08908 1/20 0.61
THRB P10828 1/20 0.61
PIM1 P11309 1/20 0.61
CYP2C9 P11712 1/20 0.61
MAOA P21397 1/20 0.61
SLC6A2 P23975 1/20 0.61
HTR2A P28223 1/20 0.61
AGTR1 P30556 1/20 0.61
CCKBR P32239 1/20 0.61
MC4R P32245 1/20 0.61
CYP2C19 P33261 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Teriflunomide SCHEMBL21380 0.90 DHODH (0.72) DHODHNPC1RAB9AHTTGMNN
SCHEMBL24047119 0.83 HTT (0.44) DHODHNPC1RAB9AHTTGMNN
SCHEMBL30107111 0.83 HTT (0.44) DHODHNPC1RAB9AHTTGMNN
Leflunomide SCHEMBL29271960 0.79 RAB9A (0.92) DHODHNPC1RAB9AHTTGMNN
SCHEMBL24047619 0.79 DHODH (0.64) DHODHNPC1RAB9AHTTGMNN
SCHEMBL19034 0.78 SMN1; SMN2 (0.61) DHODHNPC1RAB9AHTTGMNN
SCHEMBL29625262 0.78 SMN1; SMN2 (0.61) DHODHNPC1RAB9AHTTGMNN
SCHEMBL5914884 0.78 DHODH (0.65) DHODHRAB9AHTTLMNACYP1A2
SCHEMBL5914882 0.78 DHODH (0.65) DHODHRAB9AHTTLMNACYP1A2
SCHEMBL905302 0.78 DHODH (0.65) DHODHRAB9AHTTLMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020006381-A1 Method for finding nucleotide synthesis inhibitors having fewer side effects SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2002-01-17 US disclosed